| 1 |
32692785 | Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization. | 2020 |
1 |
| 2 |
30448465 | Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride. | 2019 May 1 |
1 |
| 3 |
23979838 | Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways. | 2013 Nov |
1 |
| 4 |
21561378 | Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors. | 2011 Oct |
1 |
| 5 |
19782075 | Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. | 2010 Jun |
1 |
| 6 |
20032300 | Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. | 2010 Feb 15 |
2 |
| 7 |
20617325 | Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. | 2010 Nov |
3 |
| 8 |
19429119 | Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. | 2009 May 22 |
2 |
| 9 |
16257959 | GSK-3beta directly phosphorylates and activates MARK2/PAR-1. | 2005 Dec 30 |
2 |
| 10 |
11602330 | Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. | 2001 Oct 26 |
1 |